JP2019531706A - 術前および術中の組織の局在化および視覚化のための組織特異的マーカー - Google Patents

術前および術中の組織の局在化および視覚化のための組織特異的マーカー Download PDF

Info

Publication number
JP2019531706A
JP2019531706A JP2019507152A JP2019507152A JP2019531706A JP 2019531706 A JP2019531706 A JP 2019531706A JP 2019507152 A JP2019507152 A JP 2019507152A JP 2019507152 A JP2019507152 A JP 2019507152A JP 2019531706 A JP2019531706 A JP 2019531706A
Authority
JP
Japan
Prior art keywords
tissue
seq
aptamer
specific marker
parathyroid
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Pending
Application number
JP2019507152A
Other languages
English (en)
Japanese (ja)
Other versions
JP2019531706A5 (cg-RX-API-DMAC7.html
Inventor
ダルマ‐ワイズハウズ,デニス
ヴェイザー,アレックス
ブレデンカンプ,ジェイムズ
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Invuity Inc
Original Assignee
Invuity Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Invuity Inc filed Critical Invuity Inc
Publication of JP2019531706A publication Critical patent/JP2019531706A/ja
Publication of JP2019531706A5 publication Critical patent/JP2019531706A5/ja
Pending legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/006—Biological staining of tissues in vivo, e.g. methylene blue or toluidine blue O administered in the buccal area to detect epithelial cancer cells, dyes used for delineating tissues during surgery
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/0059—Measuring for diagnostic purposes; Identification of persons using light, e.g. diagnosis by transillumination, diascopy, fluorescence
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/0019—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules
    • A61K49/0021—Fluorescence in vivo characterised by the fluorescent group, e.g. oligomeric, polymeric or dendritic molecules the fluorescent group being a small organic molecule
    • A61K49/0041—Xanthene dyes, used in vivo, e.g. administered to a mice, e.g. rhodamines, rose Bengal
    • A61K49/0043—Fluorescein, used in vivo
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K49/00—Preparations for testing in vivo
    • A61K49/001—Preparation for luminescence or biological staining
    • A61K49/0013—Luminescence
    • A61K49/0017—Fluorescence in vivo
    • A61K49/005—Fluorescence in vivo characterised by the carrier molecule carrying the fluorescent agent
    • A61K49/0054—Macromolecular compounds, i.e. oligomers, polymers, dendrimers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N15/00—Mutation or genetic engineering; DNA or RNA concerning genetic engineering, vectors, e.g. plasmids, or their isolation, preparation or purification; Use of hosts therefor
    • C12N15/09—Recombinant DNA-technology
    • C12N15/11—DNA or RNA fragments; Modified forms thereof; Non-coding nucleic acids having a biological activity
    • C12N15/115—Aptamers, i.e. nucleic acids binding a target molecule specifically and with high affinity without hybridising therewith ; Nucleic acids binding to non-nucleic acids, e.g. aptamers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • A61B2090/3937—Visible markers
    • A61B2090/395—Visible markers with marking agent for marking skin or other tissue
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B5/00—Measuring for diagnostic purposes; Identification of persons
    • A61B5/48—Other medical applications
    • A61B5/4887—Locating particular structures in or on the body
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61B—DIAGNOSIS; SURGERY; IDENTIFICATION
    • A61B90/00—Instruments, implements or accessories specially adapted for surgery or diagnosis and not covered by any of the groups A61B1/00 - A61B50/00, e.g. for luxation treatment or for protecting wound edges
    • A61B90/39—Markers, e.g. radio-opaque or breast lesions markers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/10—Type of nucleic acid
    • C12N2310/16—Aptamers
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/33—Chemical structure of the base
    • C12N2310/335—Modified T or U
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N2310/00—Structure or type of the nucleic acid
    • C12N2310/30—Chemical structure
    • C12N2310/35—Nature of the modification
    • C12N2310/351—Conjugate
    • C12N2310/3517—Marker; Tag

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Biomedical Technology (AREA)
  • General Health & Medical Sciences (AREA)
  • Genetics & Genomics (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Physics & Mathematics (AREA)
  • Epidemiology (AREA)
  • Chemical & Material Sciences (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Wood Science & Technology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Biotechnology (AREA)
  • General Engineering & Computer Science (AREA)
  • Biophysics (AREA)
  • Surgery (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Pathology (AREA)
  • Medical Informatics (AREA)
  • Optics & Photonics (AREA)
  • Biodiversity & Conservation Biology (AREA)
  • Biochemistry (AREA)
  • Oncology (AREA)
  • Plant Pathology (AREA)
  • Microbiology (AREA)
  • Oral & Maxillofacial Surgery (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Investigating Or Analysing Materials By The Use Of Chemical Reactions (AREA)
JP2019507152A 2016-08-12 2017-08-11 術前および術中の組織の局在化および視覚化のための組織特異的マーカー Pending JP2019531706A (ja)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662374213P 2016-08-12 2016-08-12
US62/374,213 2016-08-12
US201762528006P 2017-06-30 2017-06-30
US62/528,006 2017-06-30
PCT/US2017/046514 WO2018031894A1 (en) 2016-08-12 2017-08-11 Tissue specific markers for preoperative and intraoperative localization and visualization of tissue

Publications (2)

Publication Number Publication Date
JP2019531706A true JP2019531706A (ja) 2019-11-07
JP2019531706A5 JP2019531706A5 (cg-RX-API-DMAC7.html) 2020-11-19

Family

ID=61160616

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2019507152A Pending JP2019531706A (ja) 2016-08-12 2017-08-11 術前および術中の組織の局在化および視覚化のための組織特異的マーカー

Country Status (7)

Country Link
US (2) US20180043037A1 (cg-RX-API-DMAC7.html)
EP (1) EP3497244A4 (cg-RX-API-DMAC7.html)
JP (1) JP2019531706A (cg-RX-API-DMAC7.html)
CN (1) CN109804071A (cg-RX-API-DMAC7.html)
AU (1) AU2017308059A1 (cg-RX-API-DMAC7.html)
CA (1) CA3033188A1 (cg-RX-API-DMAC7.html)
WO (1) WO2018031894A1 (cg-RX-API-DMAC7.html)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP3414330A4 (en) 2016-02-08 2019-07-03 Vitrisa Therapeutics, Inc. COMPOSITIONS WITH IMPROVED INTRAVITREAL HALF TIME AND USES THEREOF
US10575801B2 (en) 2016-08-11 2020-03-03 Prismatic Sensors Ab Photon counting detector
WO2018148333A1 (en) * 2017-02-08 2018-08-16 Vitrisa Therapeutics, Inc. Compositions with improved intravitreal half-life and uses thereof
JP2020529444A (ja) * 2017-08-09 2020-10-08 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 口腔ケア用途のためのアプタマー
JP2021523454A (ja) 2018-05-17 2021-09-02 ザ プロクター アンド ギャンブル カンパニーThe Procter & Gamble Company 毛髪分析のためのシステム及び方法
MX2020012225A (es) 2018-05-17 2021-01-29 Procter & Gamble Sistemas y metodos para el analisis de la cobertura del cabello.
HK1257467A2 (zh) * 2018-06-22 2019-10-18 Master Dynamic Limited 癌症细胞检测和成像系统,过程和制品
WO2020005326A1 (en) 2018-06-29 2020-01-02 The Procter & Gamble Company Aptamers for personal care applications
EP3956451A1 (en) 2019-04-16 2022-02-23 The Procter & Gamble Company Aptamers for odor control applications
CN110441242A (zh) * 2019-08-14 2019-11-12 郑州大学 基于金刚石微悬臂梁的气体检测系统和方法
WO2021072289A1 (en) 2019-10-10 2021-04-15 Alume Biosciences, Inc. Methods and systems using peptides for targeting and mapping human nerves in image guided surgery, diagnostics and therapeutic delivery
IT202000014671A1 (it) * 2020-06-18 2021-12-18 Consiglio Nazionale Ricerche Aptameri antitumorali e loro usi
KR20230137930A (ko) * 2021-01-14 2023-10-05 알룸 바이오사이언시스 인코포레이티드 수술 절차에서 요관을 가시화하기 위한 방법 및 조성물
US12488512B2 (en) 2021-04-14 2025-12-02 Cilag Gmbh International Utilizing contextual parameters of one or more surgical devices to predict a frequency interval for displaying surgical information
US12039732B2 (en) 2021-04-14 2024-07-16 The Procter & Gamble Company Digital imaging and learning systems and methods for analyzing pixel data of a scalp region of a users scalp to generate one or more user-specific scalp classifications

Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010121023A2 (en) * 2009-04-15 2010-10-21 The Regents Of The University Of California Peptides and aptamers for targeting of neuron or nerves
US20150305623A1 (en) * 2014-04-23 2015-10-29 Invuity, Inc. Methods for localizing and treating a parathyroid adenoma
US9353154B2 (en) * 2010-09-02 2016-05-31 Avelas Biosciences, Inc. Compositions for labeling nerves and methods of use

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP4235157A3 (en) * 2008-07-30 2023-11-22 Vanderbilt University Process and system for intra-operative use of fluorescence and applications of same
CN102458396B (zh) * 2009-04-15 2017-05-10 兰休斯医疗成像公司 使用抗坏血酸稳定化放射性药物组合物
AU2013361323B2 (en) * 2012-12-19 2018-09-06 Caris Science, Inc. Compositions and methods for aptamer screening
CN103290019B (zh) * 2013-06-14 2014-03-12 严鹏科 一种动脉粥样硬化的靶向适配子及其制备方法和应用
EP3019613B1 (en) * 2013-07-09 2020-03-11 University of Central Lancashire Aptamers against glioma cells
CN105675605A (zh) * 2016-03-29 2016-06-15 中国药科大学 一种利用适配体功能化的金纳米颗粒检测胆汁酸的方法

Patent Citations (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010121023A2 (en) * 2009-04-15 2010-10-21 The Regents Of The University Of California Peptides and aptamers for targeting of neuron or nerves
US9353154B2 (en) * 2010-09-02 2016-05-31 Avelas Biosciences, Inc. Compositions for labeling nerves and methods of use
US20150305623A1 (en) * 2014-04-23 2015-10-29 Invuity, Inc. Methods for localizing and treating a parathyroid adenoma

Non-Patent Citations (2)

* Cited by examiner, † Cited by third party
Title
MOON, J.ET.AL.: "Comparison of whole-cell SELEX methods for the identification of staphylococcus aureus-specific DNA", SENSORS, vol. 15, JPN7021002725, 2015, pages 8884 - 8897, ISSN: 0004553270 *
VIAL. S. ET.AL.: "Peptide-grafted nanodiamonds: Preparation, cytotoxicity and uptake in cells", CHEMBIOCHEM, vol. 9, JPN7021002724, 2008, pages 2113 - 2119, ISSN: 0004553271 *

Also Published As

Publication number Publication date
EP3497244A1 (en) 2019-06-19
CN109804071A (zh) 2019-05-24
CA3033188A1 (en) 2018-02-15
WO2018031894A1 (en) 2018-02-15
US20210106696A1 (en) 2021-04-15
US20180043037A1 (en) 2018-02-15
AU2017308059A1 (en) 2019-02-21
EP3497244A4 (en) 2020-04-15

Similar Documents

Publication Publication Date Title
US20210106696A1 (en) Tissue specific markers for preoperative and intraoperative localization and visualization of tissue
Rosenthal et al. The status of contemporary image-guided modalities in oncologic surgery
USRE45916E1 (en) Intraoperative imaging of renal cortical tumors and cysts
Keating et al. Novel methods of intraoperative localization and margin assessment of pulmonary nodules
Marano et al. Application of fluorescence in robotic general surgery: review of the literature and state of the art
Swanson et al. Fluorescent cancer-selective alkylphosphocholine analogs for intraoperative glioma detection
WO2008050255A2 (en) Contrast agents for detecting prostate cancer
ES2828954T3 (es) Péptido de localización específica de uPAR para su uso en la formación peroperatoria de imágenes ópticas de cáncer invasivo
CN106029108A (zh) 特异性结合坏死细胞的突破性平台技术
Liberman et al. Color doppler ultrasound and gamma imaging of intratumorally injected 500 nm iron–silica nanoshells
CN108495655A (zh) 用于组织区分例如用于术中可视化的成像系统和方法
Ma et al. High-precision detection and navigation surgery of colorectal cancer micrometastases
Géczi et al. Near-infrared fluorescence guided surgery: State of the evidence from a health technology assessment perspective
De la Garza-Ramos et al. Fluorescent techniques in spine surgery
Hayashi et al. Development of a non-blurring, dual-imaging tissue marker for gastrointestinal tumor localization
Tao et al. Discovery of fatty acid translocase CD36-targeting near-infrared fluorescent probe enables visualization and imaging-guided surgery for glioma
JP2017536359A (ja) 診断及び治療用途のマイクロバブルテザー
CN114835723B (zh) Psma荧光分子探针、制备方法及试剂盒
Liang et al. Clinical fluorescent probes: mechanisms, advantages and inspirations
Zeng et al. Targeting and imaging colorectal cancer by activatable cell-penetrating peptides
KR101405440B1 (ko) 인테그린αvβ3에 특이적 압타머 및 이의 용도
CN115811954A (zh) 靶向荧光标记和柔性探头的结合使用
Barberio et al. Endoscopic preoperative tattooing and marking in the gastrointestinal tract: a systematic review of alternative methods
WO2006095936A1 (en) Nanohybrid particles for diagnosis and treatment of tumor
US8691183B2 (en) Means for the detection and treatment of prostate cells

Legal Events

Date Code Title Description
A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200807

A621 Written request for application examination

Free format text: JAPANESE INTERMEDIATE CODE: A621

Effective date: 20200807

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20200915

A521 Request for written amendment filed

Free format text: JAPANESE INTERMEDIATE CODE: A523

Effective date: 20201006

A977 Report on retrieval

Free format text: JAPANESE INTERMEDIATE CODE: A971007

Effective date: 20210618

A131 Notification of reasons for refusal

Free format text: JAPANESE INTERMEDIATE CODE: A131

Effective date: 20210716

A02 Decision of refusal

Free format text: JAPANESE INTERMEDIATE CODE: A02

Effective date: 20220301